HomeTagFoot and Ankle Archives - Paragon28

Paragon 28 (NYSE: FNA) rings The Opening Bell®

The New York Stock Exchange welcomes Paragon 28 (NYSE: FNA), today, Friday, October 15, 2021, in celebration of its Initial Public Offering. To honor the occasion, Albert DaCosta, President and CEO, and his mother, Amy DaCosta, joined by John Tuttle, NYSE Vice Chairman and Chief Commercial Officer, ring The Opening Bell®.

Photo Credit: NYSE

ENGLEWOOD, Colo., Oct. 15, 2021 /PRNewswire/ — Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the pricing of its initial public offering of 7,812,500 shares of its common stock at a public offering price of $16.00 per share, for total gross proceeds of $125.0 million, before deducting underwriting...

AVGAS 2016

Paragon 28® was well represented at American College of Foot and Ankle Surgeons (ACFAS) Meeting on February 11th-14th. Management, sales representatives and engineers from Paragon 28 were on-hand to demonstrate and exhibit our multiple product lines to the thousands of foot and ankle surgeons in attendance. A Paragon 28 hosted event took place on Friday, February...

Paragon 28 Logo
14445 Grasslands Dr. Englewood, CO 80112

Follow us:

CALL US

The name “Paragon 28” was chosen by design — to never lose focus on our goal to advance the science of foot and ankle surgery.

© 2021 Paragon 28, Inc.

Privacy Policy